Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$161.01 - $317.85 $65,370 - $129,047
406 Added 2.8%
14,891 $4.71 Million
Q3 2023

Dec 19, 2023

SELL
$164.66 - $218.08 $264,114 - $349,800
-1,604 Reduced 9.97%
14,485 $2.45 Million
Q3 2023

Nov 15, 2023

SELL
$164.66 - $218.08 $264,114 - $349,800
-1,604 Reduced 9.97%
14,485 $2.45 Million
Q2 2023

Dec 19, 2023

BUY
$176.32 - $240.22 $282,817 - $385,312
1,604 Added 11.07%
16,089 $3.49 Million
Q2 2023

Aug 15, 2023

BUY
$176.32 - $240.22 $2.84 Million - $3.86 Million
16,089 New
16,089 $3.49 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.